SACCHAROMYCES CEREVISIAE

SACCHAROMYCES CEREVISIAE was reported 919 times

SACCHAROMYCES CEREVISIAE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 DIFFUSE AXONAL INJURY 9 0.1084
1 AURICULOTEMPORAL SYNDROME 1 0.1000
2 SEPTIC NECROSIS 3 0.0833
3 TUMOUR INFLAMMATION 6 0.0536
4 EPILEPTIC ENCEPHALOPATHY 10 0.0448
5 APPLICATION SITE INJURY 6 0.0316
6 MITRAL VALVE SCLEROSIS 5 0.0289
7 PULMONARY PNEUMATOCELE 2 0.0282
8 HYDROCHOLECYSTIS 5 0.0270
9 ALCOHOLIC KETOACIDOSIS 1 0.0256
10 AUDIOGRAM ABNORMAL 1 0.0250
11 AUTOIMMUNE EYE DISORDER 1 0.0238
12 UMBILICAL DISCHARGE 2 0.0233
13 EYELID EROSION 2 0.0230
14 GASTROOESOPHAGEAL SPHINCTER INSUFFICIENCY 5 0.0226
15 APPLICATION SITE OEDEMA 6 0.0185
16 DACRYOADENITIS ACQUIRED 1 0.0179
17 POLYMERASE CHAIN REACTION POSITIVE 6 0.0172
18 AMYOTROPHY 6 0.0155
19 CHRONIC IDIOPATHIC PAIN SYNDROME 1 0.0125
20 INFUSION SITE INJURY 2 0.0114
21 ACCESSORY SPLEEN 1 0.0111
22 ORGANIC BRAIN SYNDROME 2 0.0106
23 ALLERGY TO IMMUNOGLOBULIN THERAPY 1 0.0092
24 BLOOD LACTIC ACID ABNORMAL 1 0.0089
25 WHITE MATTER LESION 11 0.0087
26 NECROSIS ISCHAEMIC 4 0.0087
27 EJECTION FRACTION 5 0.0086
28 CHRONIC LEFT VENTRICULAR FAILURE 3 0.0083
29 BRACHIOCEPHALIC VEIN THROMBOSIS 1 0.0081
30 ENTEROBACTER SEPSIS 3 0.0081
31 NEOVASCULARISATION 2 0.0076
32 CARDIOVASCULAR INSUFFICIENCY 12 0.0074
33 BACTERIAL ABDOMINAL INFECTION 1 0.0068
34 CATHETER SITE MASS 1 0.0066
35 CEREBRAL CONGESTION 1 0.0060
36 INFLAMMATION OF WOUND 2 0.0060
37 GAIT SPASTIC 2 0.0058
38 BONE NEOPLASM 6 0.0056
39 CUTANEOUS CALCIFICATION 1 0.0055
40 BENIGN PANCREATIC NEOPLASM 1 0.0053
41 CATHETER SITE INDURATION 1 0.0052
42 ANAEMIA FOLATE DEFICIENCY 1 0.0052
43 ADULT FAILURE TO THRIVE 1 0.0047
44 PNEUMONIA STREPTOCOCCAL 5 0.0046
45 DEFAECATION DISORDER 3 0.0045
46 PSEUDOMEMBRANOUS COLITIS 10 0.0045
47 CORONARY ANGIOPLASTY 2 0.0044
48 NEEDLE FATIGUE 2 0.0044
49 CEREBRAL NOCARDIOSIS 1 0.0043
50 MASTOCYTOSIS 2 0.0042
51 CHRONIC DISEASE 1 0.0039
52 CARBOHYDRATE ANTIGEN 19-9 INCREASED 2 0.0038
53 HYPERMETABOLISM 2 0.0038
54 CATHETER SITE THROMBOSIS 1 0.0036
55 DAIRY INTOLERANCE 1 0.0036
56 COLON DYSPLASIA 1 0.0035
57 MUCOSAL DRYNESS 7 0.0035
58 BACTERIAL VULVOVAGINITIS 1 0.0035
59 LACRIMAL DISORDER 2 0.0034
60 CATHETER SITE HAEMATOMA 1 0.0034
61 GASTROINTESTINAL WALL THICKENING 5 0.0033
62 BETA HAEMOLYTIC STREPTOCOCCAL INFECTION 4 0.0032
63 CLOSTRIDIUM TEST POSITIVE 7 0.0032
64 THYROXINE FREE INCREASED 2 0.0031
65 COLORECTAL ADENOMA 1 0.0031
66 GENE MUTATION 6 0.0030
67 INFUSION SITE DISCHARGE 5 0.0028
68 OBSTRUCTIVE SLEEP APNOEA SYNDROME 4 0.0027
69 ESCHAR 2 0.0027
70 VITAMIN B12 INCREASED 2 0.0025
71 AORTIC OCCLUSION 1 0.0024
72 PERIORBITAL PAIN 2 0.0024
73 INFECTED BITE 2 0.0024
74 AORTIC ARTERIOSCLEROSIS 6 0.0023
75 RELAPSING-REMITTING MULTIPLE SCLEROSIS 2 0.0023
76 BREAST SWELLING 6 0.0022
77 INFUSION SITE RASH 3 0.0022
78 BODY MASS INDEX DECREASED 1 0.0022
79 CHLOASMA 1 0.0022
80 FACET JOINT SYNDROME 7 0.0021
81 URINARY TRACT OBSTRUCTION 5 0.0021
82 PROSTATE INFECTION 2 0.0021
83 NEOPLASM RECURRENCE 7 0.0021
84 HEPATIC CYST 7 0.0021
85 APPLICATION SITE ACNE 1 0.0020
86 ARTIFICIAL CROWN PROCEDURE 1 0.0020
87 ANAEMIA VITAMIN B12 DEFICIENCY 1 0.0020
88 SKIN OEDEMA 2 0.0020
89 MIXED LIVER INJURY 6 0.0020
90 BONE EROSION 7 0.0020
91 BUTTERFLY RASH 2 0.0020
92 STOMA COMPLICATION 2 0.0020
93 ABDOMINAL INJURY 1 0.0019
94 MEGACOLON 3 0.0019
95 SLEEP DEFICIT 4 0.0019
96 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
97 INNER EAR DISORDER 2 0.0019
98 OCULOGYRIC CRISIS 4 0.0019
99 CORNEAL EROSION 1 0.0019
100 INFUSION SITE BRUISING 4 0.0019
101 INFUSION SITE MASS 2 0.0018
102 GASTROINTESTINAL SOUNDS ABNORMAL 9 0.0018
103 BLOOD MAGNESIUM ABNORMAL 1 0.0018
104 COLECTOMY TOTAL 1 0.0018
105 BUNION OPERATION 1 0.0018
106 IRON DEFICIENCY 8 0.0018
107 RECTAL ULCER 2 0.0017
108 SKIN ABRASION 8 0.0017
109 RECTAL PROLAPSE 2 0.0017
110 ESSENTIAL HYPERTENSION 3 0.0016
111 NOCARDIOSIS 4 0.0016
112 INFUSION SITE IRRITATION 2 0.0016
113 AUTOIMMUNE COLITIS 1 0.0016
114 RHINOVIRUS INFECTION 6 0.0015
115 BLOOD IMMUNOGLOBULIN A DECREASED 1 0.0015
116 CELL DEATH 3 0.0015
117 ACUTE LEFT VENTRICULAR FAILURE 1 0.0015
118 APPLICATION SITE DISCOLOURATION 6 0.0015
119 EMBOLISM 12 0.0014
120 LARGE INTESTINE PERFORATION 10 0.0014
121 INFUSION SITE SWELLING 9 0.0014
122 JOINT INSTABILITY 2 0.0014
123 BUNDLE BRANCH BLOCK LEFT 6 0.0014
124 CERVICAL RADICULOPATHY 1 0.0014
125 ANTIBODY TEST ABNORMAL 1 0.0014
126 HYPERTONIC BLADDER 4 0.0014
127 DRUG TOLERANCE 7 0.0014
128 APALLIC SYNDROME 1 0.0014
129 ACCOMMODATION DISORDER 1 0.0014
130 TOOTH DISCOLOURATION 4 0.0014
131 BLUNTED AFFECT 1 0.0014
132 INFUSION SITE INDURATION 2 0.0013
133 CHOLESTATIC LIVER INJURY 3 0.0013
134 CARDIAC INFECTION 1 0.0013
135 ANAL INCONTINENCE 12 0.0013
136 ASPIRATION PLEURAL CAVITY 1 0.0013
137 ORAL MUCOSAL ERYTHEMA 2 0.0013
138 CLOSTRIDIUM DIFFICILE INFECTION 28 0.0013
139 CORNEAL TRANSPLANT 1 0.0013
140 GASTROINTESTINAL STOMA COMPLICATION 2 0.0013
141 INFUSION SITE PRURITUS 4 0.0013
142 HUMERUS FRACTURE 6 0.0012
143 CARTILAGE ATROPHY 1 0.0012
144 HORMONE LEVEL ABNORMAL 6 0.0012
145 ARTHRITIS BACTERIAL 5 0.0012
146 INFUSION SITE HAEMORRHAGE 4 0.0012
147 RECTAL ABSCESS 2 0.0012
148 COVID-19 PNEUMONIA 14 0.0012
149 AORTIC VALVE INCOMPETENCE 5 0.0012
150 FEMORAL NECK FRACTURE 6 0.0012
151 INFUSION SITE PAIN 15 0.0012
152 AORTIC VALVE STENOSIS 2 0.0011
153 MENINGITIS ASEPTIC 5 0.0011
154 BLOOD MAGNESIUM INCREASED 1 0.0011
155 ANAEMIA OF CHRONIC DISEASE 1 0.0011
156 MONOPARESIS 2 0.0011
157 TACHYPNOEA 15 0.0011
158 HAEMOGLOBIN INCREASED 5 0.0011
159 HYPOMANIA 4 0.0011
160 BLOOD CHOLESTEROL DECREASED 2 0.0011
161 STOMA SITE ERYTHEMA 2 0.0011
162 CATHETER SITE SWELLING 1 0.0011
163 IMPATIENCE 2 0.0011
164 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
165 CLOSTRIDIUM DIFFICILE COLITIS 11 0.0010
166 BLOOD IRON ABNORMAL 1 0.0010
167 MULTI-ORGAN DISORDER 2 0.0010
168 HYPERVOLAEMIA 5 0.0010
169 RENAL CYST 8 0.0010
170 BLOOD IMMUNOGLOBULIN M DECREASED 1 0.0010
171 BRAIN HYPOXIA 1 0.0010
172 FOAMING AT MOUTH 2 0.0010
173 EMERGENCY CARE 3 0.0010
174 FAECES SOFT 7 0.0010
175 LIVEDO RETICULARIS 2 0.0010
176 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
177 BRAIN OEDEMA 12 0.0009
178 DEVICE CONNECTION ISSUE 2 0.0009
179 BLOOD SODIUM ABNORMAL 1 0.0009
180 DUODENAL ULCER PERFORATION 7 0.0009
181 HEPATIC PAIN 4 0.0009
182 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 8 0.0009
183 MULTIPLE ALLERGIES 7 0.0009
184 LARGE INTESTINAL HAEMORRHAGE 2 0.0009
185 CATHETER SITE DISCHARGE 1 0.0009
186 WOUND DEHISCENCE 3 0.0009
187 ACUTE RESPIRATORY FAILURE 17 0.0009
188 BLOOD LOSS ANAEMIA 2 0.0009
189 VASCULAR DEVICE INFECTION 4 0.0009
190 DENGUE FEVER 2 0.0009
191 ADMINISTRATION SITE PAIN 1 0.0009
192 HAIR GROWTH ABNORMAL 6 0.0009
193 ALLODYNIA 1 0.0009
194 POLYURIA 7 0.0009
195 TYPE I HYPERSENSITIVITY 3 0.0009
196 GANGRENE 5 0.0008
197 CHRONIC RESPIRATORY FAILURE 1 0.0008
198 CUTANEOUS VASCULITIS 3 0.0008
199 DECREASED IMMUNE RESPONSIVENESS 8 0.0008
200 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
201 MUCOUS STOOLS 4 0.0008
202 LABYRINTHITIS 2 0.0008
203 TONGUE OEDEMA 3 0.0008
204 ENDOCARDITIS 4 0.0008
205 BLOOD CHLORIDE DECREASED 2 0.0008
206 DACRYOSTENOSIS ACQUIRED 1 0.0008
207 EAR PAIN 15 0.0008
208 URINE OUTPUT INCREASED 2 0.0008
209 VULVOVAGINAL MYCOTIC INFECTION 3 0.0008
210 FOOD CRAVING 4 0.0008
211 TRICUSPID VALVE INCOMPETENCE 6 0.0008
212 SENSORY LOSS 6 0.0007
213 MYCOBACTERIUM AVIUM COMPLEX INFECTION 2 0.0007
214 BREAST CANCER METASTATIC 8 0.0007
215 SHOULDER ARTHROPLASTY 2 0.0007
216 BLOOD SODIUM INCREASED 2 0.0007
217 ABDOMINAL RIGIDITY 2 0.0007
218 SKIN WRINKLING 2 0.0007
219 PERIPHERAL ISCHAEMIA 3 0.0007
220 CLUSTER HEADACHE 1 0.0007
221 AGORAPHOBIA 1 0.0007
222 STOMA SITE DISCHARGE 2 0.0007
223 ORAL FUNGAL INFECTION 2 0.0007
224 MENSTRUAL DISORDER 6 0.0007
225 NECROSIS 4 0.0007
226 CHRONIC FATIGUE SYNDROME 1 0.0007
227 LIP OEDEMA 3 0.0007
228 ESCHERICHIA URINARY TRACT INFECTION 3 0.0007
229 CONNECTIVE TISSUE DISORDER 1 0.0007
230 JOINT LOCK 2 0.0007
231 BLOOD ELECTROLYTES DECREASED 1 0.0007
232 DERMATITIS CONTACT 8 0.0007
233 DIVERTICULUM INTESTINAL 3 0.0007
234 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
235 BILIARY DILATATION 1 0.0007
236 ODYNOPHAGIA 4 0.0007
237 PROSTATITIS 2 0.0007
238 INSURANCE ISSUE 10 0.0007
239 ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC 1 0.0007
240 ATRIOVENTRICULAR BLOCK 5 0.0006
241 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 5 0.0006
242 BLOOD BLISTER 2 0.0006
243 BLOOD CREATININE DECREASED 2 0.0006
244 BRAIN FOG 10 0.0006
245 SEASONAL ALLERGY 9 0.0006
246 FAECAL CALPROTECTIN INCREASED 2 0.0006
247 SARCOIDOSIS 3 0.0006
248 AORTIC VALVE DISEASE 1 0.0006
249 MITRAL VALVE INCOMPETENCE 7 0.0006
250 HEPATOMEGALY 6 0.0006
251 SUSPECTED COVID-19 2 0.0006
252 OTITIS MEDIA 2 0.0006
253 SKIN INJURY 2 0.0006
254 PROSTATE CANCER METASTATIC 2 0.0006
255 INFUSION SITE ERYTHEMA 5 0.0006
256 ULCER HAEMORRHAGE 4 0.0006
257 BILIARY DYSKINESIA 1 0.0006
258 DEAFNESS BILATERAL 1 0.0006
259 CACHEXIA 3 0.0006
260 REGURGITATION 2 0.0006
261 AMYLOIDOSIS 1 0.0006
262 LARGE INTESTINE POLYP 4 0.0006
263 EAR PRURITUS 2 0.0006
264 MUSCLE CONTRACTIONS INVOLUNTARY 2 0.0006
265 NECROTISING FASCIITIS 2 0.0006
266 BREAST PAIN 6 0.0006
267 COMPRESSION FRACTURE 3 0.0006
268 PRESCRIBED UNDERDOSE 11 0.0006
269 OESOPHAGITIS 6 0.0005
270 CONTRAST MEDIA ALLERGY 1 0.0005
271 THROMBOCYTOSIS 2 0.0005
272 CONDUCTION DISORDER 1 0.0005
273 HYPERKERATOSIS 3 0.0005
274 BODY TEMPERATURE ABNORMAL 1 0.0005
275 VIRAL MUTATION IDENTIFIED 2 0.0005
276 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
277 HYDRONEPHROSIS 4 0.0005
278 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
279 PROTEIN TOTAL DECREASED 2 0.0005
280 BLOOD BICARBONATE DECREASED 1 0.0005
281 FACE INJURY 2 0.0005
282 PARANASAL SINUS HYPERSECRETION 2 0.0005
283 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
284 GASTRIC INFECTION 2 0.0005
285 GINGIVAL DISORDER 2 0.0005
286 MOUTH SWELLING 3 0.0005
287 MADAROSIS 6 0.0005
288 PANIC DISORDER 2 0.0005
289 SPINAL CORD COMPRESSION 2 0.0005
290 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
291 HOSPICE CARE 5 0.0005
292 IDIOPATHIC PULMONARY FIBROSIS 2 0.0005
293 OESOPHAGEAL CANDIDIASIS 2 0.0005
294 OBSTRUCTION 2 0.0005
295 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
296 SQUAMOUS CELL CARCINOMA OF SKIN 3 0.0005
297 FUNGAL SKIN INFECTION 2 0.0005
298 TENSION 3 0.0005
299 DRY THROAT 5 0.0005
300 DECUBITUS ULCER 4 0.0005
301 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
302 ENCEPHALOPATHY 12 0.0005
303 SMALL INTESTINAL OBSTRUCTION 6 0.0005
304 DRUG LEVEL INCREASED 8 0.0005
305 CANDIDA INFECTION 8 0.0005
306 HEPATIC CYTOLYSIS 6 0.0005
307 ABSCESS LIMB 2 0.0005
308 CATHETER SITE ERYTHEMA 1 0.0005
309 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
310 HORDEOLUM 2 0.0005
311 OSTEOPENIA 7 0.0005
312 NODULE 6 0.0005
313 PRODUCT PREPARATION ISSUE 3 0.0005
314 SPINAL OSTEOARTHRITIS 4 0.0005
315 LOCALISED INFECTION 11 0.0005
316 COLONOSCOPY 1 0.0005
317 BACTERIAL TEST POSITIVE 1 0.0004
318 CORNEAL OEDEMA 1 0.0004
319 GASTROINTESTINAL INFECTION 4 0.0004
320 WRONG PRODUCT ADMINISTERED 3 0.0004
321 CHRONIC GASTRITIS 1 0.0004
322 SUSPECTED OFF LABEL USE 2 0.0004
323 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
324 MICTURITION URGENCY 5 0.0004
325 BLOOD PRESSURE DIASTOLIC INCREASED 2 0.0004
326 BLOOD CHOLESTEROL ABNORMAL 2 0.0004
327 BREAKTHROUGH PAIN 1 0.0004
328 NEPHROGENIC ANAEMIA 2 0.0004
329 HYPERTRANSAMINASAEMIA 3 0.0004
330 RENAL FUNCTION TEST ABNORMAL 2 0.0004
331 DEFAECATION URGENCY 3 0.0004
332 HYPOXIA 15 0.0004
333 THERAPY NON-RESPONDER 19 0.0004
334 GASTROINTESTINAL TOXICITY 2 0.0004
335 VULVOVAGINAL PAIN 2 0.0004
336 NOCTURIA 5 0.0004
337 ORAL DISORDER 3 0.0004
338 CARTILAGE INJURY 1 0.0004
339 PHARYNGITIS 5 0.0004
340 FLUID INTAKE REDUCED 2 0.0004
341 VEIN DISORDER 2 0.0004
342 PNEUMOCYSTIS JIROVECII PNEUMONIA 4 0.0004
343 TASTE DISORDER 8 0.0004
344 PRODUCT COLOUR ISSUE 2 0.0004
345 GAIT INABILITY 13 0.0004
346 BENIGN PROSTATIC HYPERPLASIA 2 0.0004
347 APHTHOUS ULCER 3 0.0004
348 POOR VENOUS ACCESS 4 0.0004
349 RESPIRATORY TRACT INFECTION 10 0.0004
350 TONSILLITIS 2 0.0004
351 ATRIAL FLUTTER 3 0.0004
352 HEPATIC STEATOSIS 7 0.0004
353 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
354 ANAL ABSCESS 2 0.0004
355 BEHAVIOUR DISORDER 2 0.0004
356 CHONDROPATHY 1 0.0004
357 LYMPHADENOPATHY 13 0.0004
358 PRESCRIBED OVERDOSE 7 0.0004
359 VIRAL INFECTION 12 0.0004
360 STATUS EPILEPTICUS 4 0.0004
361 PERIORBITAL SWELLING 2 0.0004
362 CHOLECYSTITIS ACUTE 2 0.0004
363 ELECTROLYTE IMBALANCE 4 0.0003
364 GASTROENTERITIS 5 0.0003
365 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
366 HYPOVOLAEMIA 2 0.0003
367 MACULAR DEGENERATION 4 0.0003
368 HYPERLIPIDAEMIA 4 0.0003
369 CENTRAL VENOUS CATHETERISATION 1 0.0003
370 FUNGAL INFECTION 11 0.0003
371 BURSITIS 4 0.0003
372 RETINAL DETACHMENT 3 0.0003
373 NERVE COMPRESSION 3 0.0003
374 IRON DEFICIENCY ANAEMIA 3 0.0003
375 DIVERTICULITIS 9 0.0003
376 GASTROINTESTINAL DISORDER 29 0.0003
377 PRODUCT DISTRIBUTION ISSUE 3 0.0003
378 FEELING COLD 9 0.0003
379 FAECES DISCOLOURED 7 0.0003
380 CHOLANGITIS 2 0.0003
381 INFUSION SITE EXTRAVASATION 2 0.0003
382 COLITIS 12 0.0003
383 HEAD INJURY 10 0.0003
384 MUSCLE ATROPHY 4 0.0003
385 ULCER 5 0.0003
386 HYPOPHAGIA 8 0.0003
387 ROTATOR CUFF SYNDROME 4 0.0003
388 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
389 AUTOIMMUNE DISORDER 3 0.0003
390 RENAL TUBULAR NECROSIS 3 0.0003
391 HYPOGAMMAGLOBULINAEMIA 2 0.0003
392 DEAFNESS NEUROSENSORY 1 0.0003
393 LIGAMENT SPRAIN 3 0.0003
394 WALKING AID USER 2 0.0003
395 CRYING 11 0.0003
396 ANXIETY DISORDER 1 0.0003
397 SEPTIC SHOCK 13 0.0003
398 CONTRAINDICATED PRODUCT ADMINISTERED 9 0.0003
399 EAR DISCOMFORT 3 0.0003
400 SCAR 5 0.0003
401 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
402 PULMONARY OEDEMA 13 0.0003
403 CERVICAL VERTEBRAL FRACTURE 1 0.0003
404 LYMPHOEDEMA 2 0.0003
405 DELIRIUM 10 0.0003
406 FIBROMYALGIA 7 0.0003
407 TENDERNESS 3 0.0003
408 FORMICATION 2 0.0003
409 HYPOMAGNESAEMIA 4 0.0003
410 URINARY TRACT INFECTION 49 0.0003
411 AORTIC STENOSIS 1 0.0003
412 BRONCHIOLITIS 1 0.0003
413 BLINDNESS UNILATERAL 4 0.0003
414 APPENDICECTOMY 1 0.0003
415 BONE LESION 1 0.0003
416 TONGUE DISORDER 2 0.0003
417 SKIN LACERATION 3 0.0003
418 END STAGE RENAL DISEASE 5 0.0003
419 BLOOD PHOSPHORUS DECREASED 1 0.0003
420 RESTLESSNESS 10 0.0003
421 STAPHYLOCOCCAL INFECTION 9 0.0003
422 DENTAL CARIES 3 0.0003
423 AMYLASE INCREASED 1 0.0003
424 URINARY INCONTINENCE 8 0.0003
425 OCULAR DISCOMFORT 3 0.0003
426 EYE INFECTION 3 0.0003
427 AUTOIMMUNE THYROIDITIS 1 0.0003
428 CATHETER SITE INFECTION 1 0.0003
429 CARDIO-RESPIRATORY ARREST 11 0.0003
430 AORTIC ANEURYSM 2 0.0003
431 MUSCULOSKELETAL CHEST PAIN 4 0.0003
432 CELLULITIS 13 0.0003
433 LIMB INJURY 7 0.0003
434 HYPOALBUMINAEMIA 2 0.0003
435 CARDIOPULMONARY FAILURE 1 0.0003
436 HAEMORRHOIDS 5 0.0003
437 GASTROINTESTINAL INFLAMMATION 2 0.0003
438 AFFECTIVE DISORDER 2 0.0003
439 BLOOD IRON DECREASED 3 0.0003
440 BLOOD ALBUMIN DECREASED 2 0.0003
441 GINGIVAL PAIN 2 0.0003
442 METABOLIC ACIDOSIS 8 0.0002
443 PLEURAL EFFUSION 15 0.0002
444 POST PROCEDURAL INFECTION 2 0.0002
445 FEELING HOT 15 0.0002
446 ABNORMAL FAECES 2 0.0002
447 HYPERAESTHESIA 2 0.0002
448 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
449 SPINAL COMPRESSION FRACTURE 2 0.0002
450 MUSCLE INJURY 2 0.0002
451 EOSINOPHIL COUNT INCREASED 2 0.0002
452 URINARY RETENTION 8 0.0002
453 TINNITUS 11 0.0002
454 INTESTINAL OBSTRUCTION 9 0.0002
455 EATING DISORDER 5 0.0002
456 VITAMIN D DECREASED 2 0.0002
457 MEDICATION ERROR 13 0.0002
458 DYSPEPSIA 23 0.0002
459 PSEUDOMONAS INFECTION 2 0.0002
460 IRRITABILITY 14 0.0002
461 BONE CANCER 1 0.0002
462 URINE OUTPUT DECREASED 2 0.0002
463 DEVICE USE ISSUE 4 0.0002
464 NAIL DISORDER 2 0.0002
465 SYRINGE ISSUE 4 0.0002
466 EOSINOPHILIA 4 0.0002
467 HYPERKALAEMIA 8 0.0002
468 GASTRITIS 6 0.0002
469 INFECTION 33 0.0002
470 COVID-19 40 0.0002
471 ORAL CANDIDIASIS 3 0.0002
472 TOOTH INFECTION 3 0.0002
473 IMMUNOSUPPRESSION 2 0.0002
474 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
475 GASTROENTERITIS VIRAL 4 0.0002
476 OEDEMA 12 0.0002
477 MOOD ALTERED 6 0.0002
478 C-REACTIVE PROTEIN INCREASED 8 0.0002
479 CYSTITIS 7 0.0002
480 BALANCE DISORDER 19 0.0002
481 GINGIVAL BLEEDING 3 0.0002
482 ABDOMINAL HERNIA 1 0.0002
483 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
484 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
485 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
486 POLLAKIURIA 9 0.0002
487 ARTHRITIS INFECTIVE 1 0.0002
488 NEPHROPATHY 2 0.0002
489 DEVICE OCCLUSION 3 0.0002
490 EYE PAIN 12 0.0002
491 ARTERIOSCLEROSIS 2 0.0002
492 HALLUCINATION 16 0.0002
493 BLOOD SODIUM DECREASED 4 0.0002
494 LEUKAEMIA 2 0.0002
495 FLATULENCE 12 0.0002
496 COLITIS MICROSCOPIC 1 0.0002
497 MUSCULOSKELETAL DISORDER 4 0.0002
498 CARDIOGENIC SHOCK 3 0.0002
499 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
500 HERNIA 4 0.0002
501 DIZZINESS POSTURAL 2 0.0002
502 SEPSIS 23 0.0002
503 INTENTIONAL PRODUCT USE ISSUE 18 0.0002
504 ATRIAL FIBRILLATION 20 0.0002
505 SKIN FISSURES 4 0.0002
506 INFLAMMATORY BOWEL DISEASE 2 0.0002
507 NASAL CONGESTION 12 0.0002
508 THERAPY CHANGE 2 0.0002
509 CARDIAC DISORDER 19 0.0002
510 CARDIOMYOPATHY 3 0.0002
511 SINUS DISORDER 4 0.0002
512 PULMONARY MASS 3 0.0002
513 COLITIS ULCERATIVE 9 0.0002
514 BLOOD PRESSURE ABNORMAL 4 0.0002
515 FALL 66 0.0002
516 CORONARY ARTERY DISEASE 6 0.0002
517 ACUTE KIDNEY INJURY 30 0.0002
518 AMMONIA INCREASED 1 0.0002
519 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
520 UPPER RESPIRATORY TRACT INFECTION 9 0.0002
521 CEREBRAL ISCHAEMIA 1 0.0002
522 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
523 TEMPERATURE INTOLERANCE 2 0.0002
524 EYE DISCHARGE 2 0.0002
525 BASAL CELL CARCINOMA 3 0.0002
526 HYPERGLYCAEMIA 7 0.0002
527 PULMONARY HYPERTENSION 4 0.0002
528 WEIGHT FLUCTUATION 2 0.0002
529 DERMATITIS 4 0.0002
530 ABDOMINAL DISCOMFORT 32 0.0002
531 PRODUCT USE COMPLAINT 3 0.0002
532 BLOOD LACTIC ACID INCREASED 1 0.0002
533 INCONTINENCE 2 0.0002
534 ANORECTAL DISCOMFORT 1 0.0002
535 DIARRHOEA 121 0.0002
536 ANAL FISTULA 1 0.0002
537 HIP FRACTURE 6 0.0002
538 ANAL FISSURE 1 0.0002
539 HEREDITARY ANGIOEDEMA 2 0.0002
540 POOR QUALITY SLEEP 4 0.0002
541 CONFUSIONAL STATE 30 0.0002
542 SINUSITIS 19 0.0002
543 LACTIC ACIDOSIS 6 0.0002
544 CHRONIC KIDNEY DISEASE 14 0.0002
545 EYE DISORDER 6 0.0002
546 ASTHENOPIA 1 0.0002
547 TOOTH FRACTURE 2 0.0002
548 FEBRILE NEUTROPENIA 12 0.0002
549 RED BLOOD CELL SEDIMENTATION RATE INCREASED 2 0.0002
550 CYSTIC FIBROSIS 1 0.0002
551 FOOT DEFORMITY 2 0.0002
552 NERVE INJURY 2 0.0002
553 RASH MACULO-PAPULAR 4 0.0002
554 PNEUMONIA 58 0.0002
555 MALNUTRITION 2 0.0002
556 ANGIOPATHY 1 0.0002
557 SKIN INFECTION 2 0.0002
558 PLATELET COUNT DECREASED 19 0.0002
559 ACUTE PULMONARY OEDEMA 1 0.0002
560 FACE OEDEMA 3 0.0002
561 COLECTOMY 1 0.0002
562 CONTUSION 17 0.0002
563 WEIGHT DECREASED 49 0.0002
564 HAEMATURIA 6 0.0002
565 CHOLECYSTECTOMY 2 0.0002
566 INTERNAL HAEMORRHAGE 2 0.0002
567 RED BLOOD CELL COUNT DECREASED 5 0.0002
568 ILLNESS 18 0.0002
569 HYPOKALAEMIA 8 0.0002
570 ABDOMINAL DISTENSION 18 0.0002
571 BLOOD CHOLESTEROL INCREASED 8 0.0002
572 DYSSTASIA 5 0.0002
573 NEUROTOXICITY 3 0.0002
574 BLOOD PRESSURE INCREASED 26 0.0002
575 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
576 DECREASED INTEREST 1 0.0002
577 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 12 0.0002
578 ATAXIA 2 0.0002
579 BACTERAEMIA 2 0.0002
580 PRODUCTIVE COUGH 8 0.0002
581 WRIST FRACTURE 2 0.0002
582 BLOOD PRESSURE INADEQUATELY CONTROLLED 1 0.0002
583 HYPERTENSION 35 0.0002
584 MUSCLE SPASTICITY 2 0.0002
585 BLOOD GLUCOSE ABNORMAL 3 0.0002
586 OROPHARYNGEAL PAIN 15 0.0002
587 CONCOMITANT DISEASE AGGRAVATED 1 0.0002
588 GENERALISED OEDEMA 2 0.0002
589 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
590 VAGINAL HAEMORRHAGE 7 0.0002
591 DRY MOUTH 13 0.0002
592 HYPONATRAEMIA 9 0.0002
593 PHOTOPHOBIA 3 0.0002
594 FOOT FRACTURE 3 0.0002
595 ABDOMINAL PAIN LOWER 4 0.0002
596 DRUG INTERACTION 25 0.0002
597 CHOLESTASIS 3 0.0002
598 POST PROCEDURAL COMPLICATION 3 0.0002
599 DRUG INTOLERANCE 15 0.0002
600 SKIN ULCER 4 0.0002
601 BLOOD PRESSURE SYSTOLIC INCREASED 3 0.0002
602 ORAL HERPES 3 0.0002
603 NERVOUSNESS 8 0.0002
604 KIDNEY INFECTION 3 0.0002
605 ASPERGILLUS INFECTION 1 0.0002
606 BEDRIDDEN 2 0.0002
607 IMMUNE SYSTEM DISORDER 2 0.0002
608 DISORIENTATION 6 0.0002
609 BACK PAIN 35 0.0002
610 ABDOMINAL PAIN 35 0.0002
611 EAR INFECTION 4 0.0002
612 SKIN DISORDER 5 0.0001
613 SWELLING 14 0.0001
614 BRONCHIECTASIS 1 0.0001
615 FEEDING DISORDER 3 0.0001
616 RASH PRURITIC 8 0.0001
617 EPISTAXIS 11 0.0001
618 GENERAL PHYSICAL HEALTH DETERIORATION 17 0.0001
619 ABNORMAL LOSS OF WEIGHT 1 0.0001
620 DECREASED APPETITE 34 0.0001
621 OSTEOPOROSIS 6 0.0001
622 RIB FRACTURE 3 0.0001
623 SKIN LESION 4 0.0001
624 BLOOD GLUCOSE DECREASED 7 0.0001
625 HAEMATOCHEZIA 8 0.0001
626 HAEMOPTYSIS 4 0.0001
627 CARPAL TUNNEL SYNDROME 2 0.0001
628 BURNING SENSATION 10 0.0001
629 CONSTIPATION 31 0.0001
630 OSTEOARTHRITIS 6 0.0001
631 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
632 IMPAIRED WORK ABILITY 3 0.0001
633 PARALYSIS 2 0.0001
634 IMPAIRED QUALITY OF LIFE 2 0.0001
635 COUGH 39 0.0001
636 PARAESTHESIA ORAL 2 0.0001
637 INCORRECT PRODUCT ADMINISTRATION DURATION 3 0.0001
638 SWELLING FACE 9 0.0001
639 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
640 COMPLICATION ASSOCIATED WITH DEVICE 2 0.0001
641 INTENTIONAL PRODUCT MISUSE 12 0.0001
642 ANAEMIA 26 0.0001
643 GAIT DISTURBANCE 26 0.0001
644 PYREXIA 47 0.0001
645 BRONCHITIS 10 0.0001
646 ARTHROPOD BITE 1 0.0001
647 TOOTH DISORDER 3 0.0001
648 COLON CANCER 2 0.0001
649 ORAL PAIN 3 0.0001
650 SPEECH DISORDER 7 0.0001
651 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 24 0.0001
652 BLOOD POTASSIUM DECREASED 4 0.0001
653 ASTHMA 15 0.0001
654 INSOMNIA 35 0.0001
655 OEDEMA PERIPHERAL 16 0.0001
656 VERTIGO 8 0.0001
657 DISCOMFORT 8 0.0001
658 NEPHROLITHIASIS 6 0.0001
659 BOWEL MOVEMENT IRREGULARITY 1 0.0001
660 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
661 NASOPHARYNGITIS 24 0.0001
662 THYROID DISORDER 2 0.0001
663 ANKLE FRACTURE 2 0.0001
664 CONCUSSION 1 0.0001
665 EJECTION FRACTION DECREASED 2 0.0001
666 APNOEA 1 0.0001
667 THERAPY PARTIAL RESPONDER 2 0.0001
668 DEHYDRATION 17 0.0001
669 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
670 ANAPHYLACTIC REACTION 7 0.0001
671 PNEUMOTHORAX 2 0.0001
672 ARTHROPATHY 7 0.0001
673 RESPIRATORY TRACT CONGESTION 2 0.0001
674 SKIN BURNING SENSATION 9 0.0001
675 SCIATICA 2 0.0001
676 NEUTROPENIA 17 0.0001
677 BLOOD PRESSURE FLUCTUATION 3 0.0001
678 INTENTIONAL OVERDOSE 8 0.0001
679 CARDIAC FAILURE 10 0.0001
680 NEURALGIA 3 0.0001
681 DEPRESSION 28 0.0001
682 BACK DISORDER 2 0.0001
683 ASPHYXIA 1 0.0001
684 LUNG DISORDER 6 0.0001
685 PRODUCT DOSE OMISSION ISSUE 36 0.0001
686 ASTHENIA 46 0.0001
687 IMPAIRED HEALING 4 0.0001
688 ERYTHEMA 25 0.0001
689 VENTRICULAR TACHYCARDIA 2 0.0001
690 ACUTE CORONARY SYNDROME 1 0.0001
691 INFUSION RELATED REACTION 8 0.0001
692 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
693 LEUKOPENIA 6 0.0001
694 PALPITATIONS 14 0.0001
695 BLOOD UREA INCREASED 2 0.0001
696 TYPE 2 DIABETES MELLITUS 4 0.0001
697 SKIN EXFOLIATION 10 0.0001
698 HAEMATEMESIS 3 0.0001
699 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 2 0.0001
700 ERECTILE DYSFUNCTION 3 0.0001
701 VISION BLURRED 16 0.0001
702 INFLAMMATION 6 0.0001
703 MUSCULOSKELETAL DISCOMFORT 2 0.0001
704 ANURIA 1 0.0001
705 HYPOACUSIS 5 0.0001
706 BLOOD MAGNESIUM DECREASED 1 0.0001
707 HAEMATOMA 3 0.0001
708 MIGRAINE 11 0.0001
709 HYPOTENSION 23 0.0001
710 MUCOSAL INFLAMMATION 3 0.0001
711 BLOOD CALCIUM INCREASED 1 0.0001
712 HEART RATE DECREASED 4 0.0001
713 DEVICE MALFUNCTION 8 0.0001
714 METASTASES TO LIVER 2 0.0001
715 BRADYCARDIA 6 0.0001
716 HEAD DISCOMFORT 2 0.0001
717 ASPARTATE AMINOTRANSFERASE INCREASED 6 0.0001
718 FEELING ABNORMAL 27 0.0001
719 PAIN IN EXTREMITY 33 0.0001
720 ABDOMINAL PAIN UPPER 23 0.0001
721 GOUT 2 0.0001
722 PAIN OF SKIN 3 0.0001
723 LEUKOCYTOSIS 2 0.0001
724 RESTLESS LEGS SYNDROME 2 0.0001
725 PANIC ATTACK 4 0.0001
726 BRAIN NEOPLASM 1 0.0001
727 DYSURIA 4 0.0001
728 FATIGUE 84 0.0001
729 MALIGNANT NEOPLASM PROGRESSION 11 0.0001
730 NECK PAIN 6 0.0001
731 THINKING ABNORMAL 2 0.0001
732 WOUND 3 0.0001
733 BLOOD CREATININE INCREASED 7 0.0001
734 BACTERIAL INFECTION 2 0.0001
735 HAEMOGLOBIN DECREASED 11 0.0001
736 DEFORMITY 1 0.0001
737 OXYGEN SATURATION DECREASED 6 0.0001
738 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
739 ARRHYTHMIA 5 0.0001
740 RENAL FAILURE 14 0.0001
741 BLOOD PRESSURE DECREASED 7 0.0001
742 HEADACHE 66 0.0001
743 PROTEINURIA 2 0.0001
744 ANGINA PECTORIS 3 0.0001
745 LETHARGY 6 0.0001
746 LOWER LIMB FRACTURE 2 0.0001
747 AFFECT LABILITY 1 0.0001
748 PERIPHERAL SWELLING 16 0.0001
749 ATELECTASIS 1 0.0001
750 CHOKING 2 0.0001
751 COELIAC DISEASE 1 0.0001
752 ALOPECIA 20 0.0001
753 LABORATORY TEST ABNORMAL 3 0.0001
754 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
755 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
756 RENAL INJURY 3 0.0001
757 HYPERHIDROSIS 13 0.0001
758 CATARACT 6 0.0001
759 BLADDER DISORDER 1 0.0001
760 MALAISE 44 0.0001
761 VOMITING 47 0.0001
762 SYNCOPE 10 0.0001
763 NAUSEA 79 0.0001
764 BRAIN INJURY 1 0.0001
765 LACRIMATION INCREASED 3 0.0001
766 PRODUCT ADMINISTRATION ERROR 2 0.0001
767 INFLUENZA 11 0.0001
768 ARTHRALGIA 41 0.0001
769 DEVICE BREAKAGE 4 0.0001
770 DYSKINESIA 4 0.0001
771 THROMBOCYTOPENIA 11 0.0001
772 WEIGHT INCREASED 22 0.0001
773 MOBILITY DECREASED 7 0.0001
774 CHEST PAIN 18 0.0001
775 LIMB DISCOMFORT 3 0.0001
776 PERITONITIS 2 0.0001
777 PRURITUS 37 0.0001
778 NERVOUS SYSTEM DISORDER 3 0.0001
779 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 5 0.0001
780 PRODUCT USE ISSUE 18 0.0001
781 BONE DENSITY DECREASED 3 0.0001
782 ECZEMA 5 0.0001
783 SEIZURE 11 0.0001
784 RENAL IMPAIRMENT 8 0.0001
785 DEPRESSED MOOD 5 0.0001
786 DYSGEUSIA 7 0.0001
787 HYPOTHYROIDISM 3 0.0001
788 RETCHING 2 0.0001
789 BODY HEIGHT DECREASED 1 0.0001
790 MOVEMENT DISORDER 3 0.0001
791 IRRITABLE BOWEL SYNDROME 2 0.0001
792 LIVER FUNCTION TEST INCREASED 2 0.0001
793 RECTAL HAEMORRHAGE 4 0.0001
794 RHINORRHOEA 6 0.0001
795 DECREASED ACTIVITY 1 0.0001
796 DEVICE LEAKAGE 4 0.0001
797 BACK INJURY 1 0.0001
798 DYSPNOEA 52 0.0001
799 CHOLELITHIASIS 3 0.0001
800 ASPIRATION 1 0.0001
801 HEART RATE INCREASED 9 0.0001
802 STEVENS-JOHNSON SYNDROME 2 0.0001
803 GLOSSODYNIA 2 0.0001
804 EYE PRURITUS 3 0.0001
805 SNEEZING 2 0.0001
806 BLOOD CALCIUM DECREASED 1 0.0001
807 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
808 LOWER RESPIRATORY TRACT INFECTION 4 0.0001
809 SKIN IRRITATION 4 0.0001
810 SKIN DISCOLOURATION 4 0.0001
811 HERPES ZOSTER 5 0.0001
812 SHOCK 2 0.0001
813 EYE IRRITATION 5 0.0001
814 HYPOAESTHESIA 13 0.0001
815 PERICARDIAL EFFUSION 2 0.0001
816 PAIN 53 0.0001
817 RASH MACULAR 3 0.0001
818 CONDITION AGGRAVATED 26 0.0001
819 DYSPHONIA 5 0.0001
820 SURGERY 5 0.0001
821 CARDIAC ARREST 7 0.0001
822 TREATMENT FAILURE 7 0.0001
823 THERAPY INTERRUPTED 6 0.0001
824 CHOLECYSTITIS 1 0.0001
825 GASTROINTESTINAL HAEMORRHAGE 7 0.0001
826 URTICARIA 14 0.0001
827 JOINT SWELLING 10 0.0001
828 PARAESTHESIA 13 0.0001
829 HYPOGLYCAEMIA 4 0.0001
830 ADRENAL INSUFFICIENCY 1 0.0001
831 PRESYNCOPE 2 0.0001
832 CARDIOMEGALY 1 0.0001
833 INJECTION SITE MASS 3 0.0001
834 PRODUCT USE IN UNAPPROVED INDICATION 20 0.0001
835 VISUAL IMPAIRMENT 10 0.0001
836 CYST 1 0.0001
837 AGEUSIA 2 0.0001
838 PNEUMONIA ASPIRATION 2 0.0001
839 DYSARTHRIA 3 0.0001
840 HOT FLUSH 6 0.0001
841 GASTRIC CANCER 2 0.0001
842 FLUID RETENTION 4 0.0001
843 HEPATITIS 2 0.0001
844 ADVERSE DRUG REACTION 7 0.0001
845 UNRESPONSIVE TO STIMULI 2 0.0001
846 EXPOSURE VIA SKIN CONTACT 2 0.0001
847 DEAFNESS 2 0.0001
848 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
849 ARTHRITIS 6 0.0001
850 JOINT STIFFNESS 2 0.0001
851 DIZZINESS 38 0.0001
852 PANCREATITIS 4 0.0001
853 DRY SKIN 10 0.0001
854 CARDIAC FAILURE CONGESTIVE 6 0.0001
855 THROMBOSIS 6 0.0001
856 DISTURBANCE IN ATTENTION 4 0.0001
857 FREQUENT BOWEL MOVEMENTS 2 0.0001
858 BLOOD BILIRUBIN INCREASED 2 0.0001
859 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
860 RESPIRATORY DISTRESS 2 0.0001
861 PROCEDURAL PAIN 2 0.0001
862 DRUG ABUSE 6 0.0001
863 ROAD TRAFFIC ACCIDENT 3 0.0001
864 COORDINATION ABNORMAL 1 0.0001
865 APHONIA 1 0.0001
866 PANCYTOPENIA 4 0.0001
867 MUSCLE SPASMS 13 0.0001
868 MULTIPLE ORGAN DYSFUNCTION SYNDROME 2 0.0001
869 PAIN IN JAW 2 0.0001
870 ANXIETY 20 0.0001
871 INTENTIONAL DOSE OMISSION 2 0.0001
872 BRONCHOSPASM 1 0.0001
873 ACCIDENTAL UNDERDOSE 1 0.0001
874 NEEDLE ISSUE 2 0.0001
875 RESPIRATORY FAILURE 5 0.0001
876 CHEST DISCOMFORT 7 0.0001
877 PSYCHOTIC DISORDER 2 0.0001
878 TACHYCARDIA 6 0.0001
879 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
880 THROAT IRRITATION 3 0.0001
881 RESPIRATORY DISORDER 2 0.0001
882 MEMORY IMPAIRMENT 9 0.0001
883 EPILEPSY 2 0.0001
884 INJECTION SITE RASH 2 0.0001
885 EMOTIONAL DISORDER 2 0.0001
886 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 3 0.0001
887 SWOLLEN TONGUE 2 0.0001
888 CYANOSIS 1 0.0001
889 DISEASE RECURRENCE 3 0.0001
890 RASH ERYTHEMATOUS 3 0.0001
891 MOOD SWINGS 2 0.0001
892 INJECTION SITE HAEMORRHAGE 5 0.0001
893 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
894 NIGHT SWEATS 2 0.0001
895 BLOOD POTASSIUM INCREASED 1 0.0001
896 OFF LABEL USE 53 0.0001
897 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
898 TREMOR 10 0.0001
899 CYTOMEGALOVIRUS INFECTION 1 0.0001
900 LIP SWELLING 2 0.0001
901 FLUSHING 6 0.0001
902 HEPATIC ENZYME INCREASED 4 0.0001
903 THERAPY CESSATION 3 0.0001
904 BLOOD GLUCOSE INCREASED 11 0.0001
905 GASTRIC DISORDER 2 0.0001
906 NEOPLASM PROGRESSION 2 0.0001
907 RASH 25 0.0001
908 INJURY 4 0.0001
909 DERMATITIS ATOPIC 3 0.0001
910 DEVICE ISSUE 5 0.0001
911 ELECTROCARDIOGRAM QT PROLONGED 2 0.0001
912 COMPLICATION OF DEVICE REMOVAL 1 0.0001
913 TREATMENT NONCOMPLIANCE 3 0.0001
914 CONJUNCTIVITIS 1 0.0001
915 EYE SWELLING 2 0.0001
916 HEPATIC FUNCTION ABNORMAL 2 0.0001
917 CEREBROVASCULAR ACCIDENT 9 0.0001
918 DYSPNOEA EXERTIONAL 2 0.0001
919 MUSCULAR WEAKNESS 6 0.0001
920 DYSPHAGIA 5 0.0001
921 PULMONARY EMBOLISM 5 0.0001
922 DIABETES MELLITUS 4 0.0001
923 PRODUCT SUBSTITUTION ISSUE 3 0.0001
924 HOSPITALISATION 8 0.0001
925 BONE PAIN 3 0.0001
926 DISEASE PROGRESSION 6 0.0001
927 ABORTION SPONTANEOUS 2 0.0000
928 SOMNOLENCE 10 0.0000
929 THERAPEUTIC RESPONSE DECREASED 3 0.0000
930 STOMATITIS 3 0.0000
931 PSORIATIC ARTHROPATHY 2 0.0000
932 BLINDNESS 2 0.0000
933 MYALGIA 8 0.0000
934 DEVICE DIFFICULT TO USE 3 0.0000
935 ANGIOEDEMA 2 0.0000
936 LIVER DISORDER 2 0.0000
937 CHROMATURIA 1 0.0000
938 SUICIDAL IDEATION 4 0.0000
939 DEATH 37 0.0000
940 CHILLS 5 0.0000
941 SLEEP DISORDER 3 0.0000
942 NEUROPATHY PERIPHERAL 4 0.0000
943 MULTIPLE SCLEROSIS 2 0.0000
944 UNDERDOSE 3 0.0000
945 INJECTION SITE ERYTHEMA 5 0.0000
946 DRY EYE 2 0.0000
947 UNEVALUABLE EVENT 3 0.0000
948 LOSS OF CONSCIOUSNESS 5 0.0000
949 ANHEDONIA 1 0.0000
950 BREAST CANCER FEMALE 1 0.0000
951 OVERDOSE 8 0.0000
952 INFLUENZA LIKE ILLNESS 3 0.0000
953 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
954 ABNORMAL DREAMS 1 0.0000
955 DRUG INEFFECTIVE 46 0.0000
956 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
957 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 7 0.0000
958 MYOCARDIAL INFARCTION 6 0.0000
959 PRODUCT STORAGE ERROR 3 0.0000
960 WHEEZING 2 0.0000
961 HYPERSENSITIVITY 6 0.0000
962 DRUG DEPENDENCE 5 0.0000
963 INCORRECT DOSE ADMINISTERED 7 0.0000
964 INJECTION SITE PRURITUS 2 0.0000
965 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
966 ANGER 1 0.0000
967 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
968 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
969 INJECTION SITE REACTION 2 0.0000
970 HAEMORRHAGE 3 0.0000
971 CEREBRAL HAEMORRHAGE 1 0.0000
972 ACCIDENTAL OVERDOSE 1 0.0000
973 AGITATION 2 0.0000
974 RHEUMATOID ARTHRITIS 3 0.0000
975 INJECTION SITE SWELLING 2 0.0000
976 INJECTION SITE BRUISING 2 0.0000
977 COMPLETED SUICIDE 2 0.0000
978 PSORIASIS 3 0.0000
979 INJECTION SITE PAIN 7 0.0000
980 NO ADVERSE EVENT 4 0.0000
981 COLORECTAL CANCER 1 0.0000
982 BLISTER 1 0.0000
983 BLADDER CANCER 1 0.0000
984 DEEP VEIN THROMBOSIS 1 0.0000
985 AMNESIA 1 0.0000
986 ADVERSE EVENT 1 0.0000
987 BREAST CANCER 1 0.0000